CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance
October 28, 2021 16:01 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study
October 21, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement
October 19, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif. and IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and...
CareDx to Report Third Quarter 2021 Financial Results
October 14, 2021 16:01 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients
October 12, 2021 10:18 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication
September 30, 2021 16:01 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Continues to Fight for Innovation in Transplantation
September 28, 2021 19:18 ET
|
CareDx, Inc.
False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc....
CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021
September 27, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Names Longtime Patient Advocate Art Torres to Board of Directors
September 15, 2021 08:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to Participate in Upcoming Conferences
September 02, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...